Clinical trial
Safety Study of S-CKD602 in Patients With Advanced Malignancies
NCT00177281 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177281 |
|---|---|
| Title | Safety Study of S-CKD602 in Patients With Advanced Malignancies |
| Official title | A Phase I Study to Evaluate the Safety and Pharmacokinetics of S-CKD602 in Patients With Advanced Malignancies |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | ALZA Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | S CKD602 |
| Enrollment | 45 |
| Start date | Sep 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: